Drug-induced transcriptional perturbations of developmental pathways in neural progenitor cells
Year: 2026
Type: article
Abstract: Developmental toxicity involves the disruption of cellular programs governing differentiation, tissue organization, and stress adaptation. Here, we evaluated drug-induced transcriptional profiles of clonazepam, celecoxib, fluoxetine, and lithium in human neural progenitor-related cell models. Genes with an absolute Characteristic Direction coefficient of |CD| ≥ 0.020 were selected for analysis. Cross-treatment comparisons identified 7 genes shared by clonazepam–celecoxib–fluoxetine, 15 by clonazepam–celecoxib–lithium, 12 by clonazepam–fluoxetine–lithium, and 14 by celecoxib–fluoxetine–lithium. Protein–protein interaction analysis linked the concordant genes to regulatory networks. STRING analysis identified a connected component comprising DDX3Y, EIF1AY, KDM5D, and USP9Y. Jensen DISEASES enrichment identified three significant terms: Pachyonychia congenita, Phagocyte bactericidal dysfunction, and Chronic granulomatous disease (adjusted P = 0.0379). CTD network-inference analysis also yielded gene–disease associations with chemical and drug induced liver injury and necrosis recurring among the selected records. Overall, these findings indicate that distinct pharmacological agents induce heterogeneous yet convergent transcriptional perturbations and provide hypothesis-generating insights into disease and phenotype associations that warrant further experimental validation in complex developmental models.
Source: In Silico Pharmacology
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,290
OpenAlex ID: W7237219074
